Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Mylan Laboratories Ltd patents


Recent patent applications related to Mylan Laboratories Ltd. Mylan Laboratories Ltd is listed as an Agent/Assignee. Note: Mylan Laboratories Ltd may have other listings under different names/spellings. We're not affiliated with Mylan Laboratories Ltd, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Mylan Laboratories Ltd-related inventors


Polymorphic forms of afatinib dimaleate

The present disclosure relates to amorphous and crystalline forms of 2-butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethyl amino)-,(2E)-, (2Z)-2-butenedioate (1:2) (afatinib dimaleate). The present disclosure also relates to process for the preparation of amorphous and crystalline forms of afatinib dimaleate. Further, the present disclosure relates to solid dispersion of amorphous afatinib dimaleate and the crystalline... Mylan Laboratories Ltd

Amorphous empagliflozin

The present disclosure relates to solid dispersion of amorphous empagliflozin and its process thereof.... Mylan Laboratories Ltd

Processes for the preparation of intermediates of raltegravir

The present disclosure provides a process for the preparation of 2-(2-amino propan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydro-pyrimidine-4-carboxamide by debenzylation of benzyl(2-{4-[(4-fluorobenzyl)carbamoyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl}propan-2-yl)carbamate. This process may be used in the synthesis of raltegravir and pharmaceutically acceptable salts thereof.... Mylan Laboratories Ltd

Process for the preparation of canagliflozin

A process for the preparation of canagliflozin. The process may be effectively implemented on an industrial scale. Several compounds useful as intermediates for the synthesis of canagliflozin (Formula 4, Formula 4a, Formula 4b and Formula 5) are also disclosed. The process involves the reduction of the compound of formula 3... Mylan Laboratories Ltd

Process for the purification of fluticasone propionate using a ketone solvent and water as anti-solvent

The present disclosure relates to an improved process for the purification of fluticasone propionate by: a) dissolving fluticasone propionate in a ketone solvent to produce a mixture, b) heating the mixture slowly for 1-2 hours to get a clear solution, c) adding water to the step (b) solution at 50-60°... Mylan Laboratories Ltd

Amorphous cobicistat solid dispersion

The present disclosure relates to a solid dispersion of amorphous cobicistat and methods of its preparation. Cobicistat may be complexed with a pharmaceutically acceptable carrier such as β-cyclodextrin or hydroxy! propyl β-cyclodextrin. The present disclosure also provides pharmaceutical formulations for administration to patients and methods of their use.... Mylan Laboratories Ltd








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Mylan Laboratories Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Mylan Laboratories Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###